{"id":20883,"date":"2025-11-07T09:48:36","date_gmt":"2025-11-07T08:48:36","guid":{"rendered":"https:\/\/www.tauli.cat\/institut\/?p=20883"},"modified":"2025-11-07T12:27:33","modified_gmt":"2025-11-07T11:27:33","slug":"li3pt-rep-una-beca-de-la-marato-per-desenvolupar-un-tractament-innovador-contra-la-pneumonia","status":"publish","type":"post","link":"https:\/\/www.tauli.cat\/institut\/actualitat\/noticies\/2025\/11\/li3pt-rep-una-beca-de-la-marato-per-desenvolupar-un-tractament-innovador-contra-la-pneumonia\/","title":{"rendered":"L\u2019I3PT rep una beca de La Marat\u00f3 per desenvolupar un tractament innovador contra la pneum\u00f2nia","gt_translate_keys":[{"key":"rendered","format":"text"}]},"content":{"rendered":"<div class=\"wpb-content-wrapper\">[vc_row][vc_column][vc_column_text css=&#8221;&#8221;]\n<ul>\n<li aria-setsize=\"-1\" data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"3\" data-list-defn-props=\"{&quot;335552541&quot;:1,&quot;335559685&quot;:720,&quot;335559991&quot;:360,&quot;469769226&quot;:&quot;Symbol&quot;,&quot;469769242&quot;:[8226],&quot;469777803&quot;:&quot;left&quot;,&quot;469777804&quot;:&quot;\uf0b7&quot;,&quot;469777815&quot;:&quot;hybridMultilevel&quot;}\" data-aria-posinset=\"1\" data-aria-level=\"1\"><strong>El projecte Carri-Air, liderat per la investigadora Aina Areny, proposa una nova estrat\u00e8gia terap\u00e8utica basada en nanoc\u00e0psules per millorar el tractament i la recuperaci\u00f3 pulmonar en pacients amb pneum\u00f2nia\u00a0<\/strong><\/li>\n<\/ul>\n<hr \/>\n<p><span data-contrast=\"auto\">La investigadora de l\u2019Institut d\u2019Investigaci\u00f3 i Innovaci\u00f3 Parc Taul\u00ed (I3PT) <\/span><strong>Aina Areny<\/strong><span data-contrast=\"auto\"> ha estat una de les benefici\u00e0ries de les beques de <\/span><strong>La Marat\u00f3 de 3Cat <\/strong><span data-contrast=\"auto\">del<\/span> <span data-contrast=\"auto\">2024, dedicada a la <\/span><strong>recerca de malalties respirat\u00f2ries<\/strong><span data-contrast=\"auto\">, patologies que afecten els pulmons, les vies a\u00e8ries i el conjunt d&#8217;\u00f2rgans i teixits necessaris per a la respiraci\u00f3, i que cada vegada tenen m\u00e9s prevalen\u00e7a en la poblaci\u00f3 a causa de factors ambientals, com la contaminaci\u00f3, i socials, com l\u2019increment de l\u2019esperan\u00e7a de vida.<\/span><span data-ccp-props=\"{&quot;134233118&quot;:true,&quot;201341983&quot;:0,&quot;335551550&quot;:6,&quot;335551620&quot;:6,&quot;335559740&quot;:240}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">El projecte seleccionat, anomenat \u201c<\/span><strong>Transformant el tractament de la pneum\u00f2nia: nanoc\u00e0rriers amb miRNAs per a la immunomodulaci\u00f3 i la reparaci\u00f3 pulmonar (Carri-Air)<\/strong><span data-contrast=\"auto\">\u201d, rebr\u00e0 un finan\u00e7ament de 398.836 euros i es dur\u00e0 a terme en col\u00b7laboraci\u00f3 amb l\u2019Institut de Ci\u00e8ncia de Materials de Barcelona (ICMAB-CSIC) i l\u2019Institut d\u2019Investigaci\u00f3 en Ci\u00e8ncies de la Salut Germans Trias i Pujol (IGTP), sota la coordinaci\u00f3 de l\u2019I3PT.\u00a0<\/span><span data-ccp-props=\"{&quot;134233117&quot;:true,&quot;134233118&quot;:true,&quot;201341983&quot;:0,&quot;335551550&quot;:6,&quot;335551620&quot;:6,&quot;335559740&quot;:240}\">\u00a0<\/span><\/p>\n<h4><b><span data-contrast=\"none\">Nanoc\u00e0psules per combatre la pneum\u00f2nia<\/span><\/b><span data-ccp-props=\"{&quot;335551550&quot;:6,&quot;335551620&quot;:6,&quot;335559739&quot;:0}\">\u00a0<\/span><\/h4>\n<p><span data-contrast=\"auto\">La <\/span><strong>pneum\u00f2nia<\/strong><span data-contrast=\"auto\"> \u00e9s una de les <\/span><strong>principals causes de morbiditat i mortalitat al m\u00f3n<\/strong><span data-contrast=\"auto\">, amb m\u00e9s de 344 milions de casos i 2,2 milions de morts anuals, segons dades del Global Burden of Diseases 2021. A m\u00e9s, sovint pot derivar en la S\u00edndrome de Dificultat Respirat\u00f2ria Aguda (SDRA), una complicaci\u00f3 greu que requereix atenci\u00f3 intensiva.<\/span><span data-ccp-props=\"{&quot;134233117&quot;:true,&quot;134233118&quot;:true,&quot;201341983&quot;:0,&quot;335551550&quot;:6,&quot;335551620&quot;:6,&quot;335559740&quot;:240}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">Els <\/span><strong>tractaments actuals<\/strong><span data-contrast=\"auto\">, basats en antibi\u00f2tics, antivirals o ter\u00e0pies de suport, <\/span><strong>tenen limitacions importants<\/strong><span data-contrast=\"auto\">, com la resist\u00e8ncia als antimicrobians i la manca de ter\u00e0pies per a la regeneraci\u00f3 del teixit pulmonar danyat.<\/span><span data-ccp-props=\"{&quot;134233117&quot;:true,&quot;134233118&quot;:true,&quot;201341983&quot;:0,&quot;335551550&quot;:6,&quot;335551620&quot;:6,&quot;335559740&quot;:240}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">Davant d\u2019aquest escenari, el <strong>projecte<\/strong><\/span> <strong>Carri-Air proposa una estrat\u00e8gia terap\u00e8utica innovadora basada en nanoc\u00e0psules biodegradables<\/strong><span data-contrast=\"auto\"> (PLGA) que permeten lliurar tres microRNAs (miRNAs) amb propietats immunomoduladores i regeneratives directament als pulmons a trav\u00e9s de la inhalaci\u00f3. Aquestes nanoc\u00e0psules, batejades com a \u201cnanoc\u00e0psules per la pneum\u00f2nia\u201d (N4P), busquen restaurar l\u2019equilibri immunitari, afavorir l\u2019eliminaci\u00f3 dels pat\u00f2gens i estimular la reparaci\u00f3 del teixit pulmonar.<\/span><span data-ccp-props=\"{&quot;134233117&quot;:true,&quot;134233118&quot;:true,&quot;201341983&quot;:0,&quot;335551550&quot;:6,&quot;335551620&quot;:6,&quot;335559740&quot;:240}\">\u00a0<\/span><\/p>\n<h4><b><span data-contrast=\"none\">Una recerca amb mirada translacional<\/span><\/b><span data-ccp-props=\"{&quot;335551550&quot;:6,&quot;335551620&quot;:6,&quot;335559739&quot;:0}\">\u00a0<\/span><\/h4>\n<p><span data-contrast=\"auto\">El projecte <\/span><strong>validar\u00e0 l\u2019efic\u00e0cia de les N4P<\/strong> <span data-contrast=\"auto\">mitjan\u00e7ant estudis in vitro, in vivo (models precl\u00ednics) i ex vivo (mostres humanes) <\/span><strong>en diferents tipus de pneum\u00f2nia, tant bacteriana com viral<\/strong><span data-contrast=\"auto\">. A m\u00e9s, tamb\u00e9 s\u2019establir\u00e0 una estrat\u00e8gia reguladora per facilitar la seva futura translaci\u00f3 cl\u00ednica.<\/span><span data-ccp-props=\"{&quot;134233117&quot;:true,&quot;134233118&quot;:true,&quot;201341983&quot;:0,&quot;335551550&quot;:6,&quot;335551620&quot;:6,&quot;335559740&quot;:240}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">\u201cEl nostre objectiu \u00e9s <\/span><strong>oferir una alternativa efica\u00e7 als tractaments actuals de la pneum\u00f2nia, reduint l\u2019estada hospital\u00e0ria, la depend\u00e8ncia de la ventilaci\u00f3 mec\u00e0nica i les complicacions derivades de les resist\u00e8ncies antimicrobianes<\/strong><span data-contrast=\"auto\">\u201d, explica la investigadora Aina Areny, que tamb\u00e9 coordinar\u00e0 l\u2019equip investigador de l\u2019I3PT format per <strong>Antoni Artigas<\/strong>, <strong>Marta Camprub\u00ed<\/strong> i <strong>Elena Campa\u00f1a<\/strong>.<\/span>[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column width=&#8221;2\/3&#8243;][vc_raw_html css=&#8221;&#8221;]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[\/vc_raw_html][\/vc_column][vc_column width=&#8221;1\/3&#8243;][\/vc_column][\/vc_row]\n<\/div>","protected":false,"gt_translate_keys":[{"key":"rendered","format":"html"}]},"excerpt":{"rendered":"<p>L&#8217;equip investigador proposa una nova estrat\u00e8gia terap\u00e8utica per al tractament i recuperaci\u00f3 de la pneum\u00f2nia, una malaltia que provoca 2,2 milions de morts anuals<\/p>\n","protected":false,"gt_translate_keys":[{"key":"rendered","format":"html"}]},"author":24,"featured_media":20885,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[1],"tags":[269,102,389],"gt_translate_keys":[{"key":"link","format":"url"}],"_links":{"self":[{"href":"https:\/\/www.tauli.cat\/institut\/wp-json\/wp\/v2\/posts\/20883"}],"collection":[{"href":"https:\/\/www.tauli.cat\/institut\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.tauli.cat\/institut\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.tauli.cat\/institut\/wp-json\/wp\/v2\/users\/24"}],"replies":[{"embeddable":true,"href":"https:\/\/www.tauli.cat\/institut\/wp-json\/wp\/v2\/comments?post=20883"}],"version-history":[{"count":16,"href":"https:\/\/www.tauli.cat\/institut\/wp-json\/wp\/v2\/posts\/20883\/revisions"}],"predecessor-version":[{"id":20919,"href":"https:\/\/www.tauli.cat\/institut\/wp-json\/wp\/v2\/posts\/20883\/revisions\/20919"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.tauli.cat\/institut\/wp-json\/wp\/v2\/media\/20885"}],"wp:attachment":[{"href":"https:\/\/www.tauli.cat\/institut\/wp-json\/wp\/v2\/media?parent=20883"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.tauli.cat\/institut\/wp-json\/wp\/v2\/categories?post=20883"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.tauli.cat\/institut\/wp-json\/wp\/v2\/tags?post=20883"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}